| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |